Titan Hopes To Tap Into Niche Drug Addiction Market With Six-Month Implant
This article was originally published in The Pink Sheet Daily
Executive Summary
Titan says compliance and abuse-resistance will hook payers on new long-acting formulations vs. low-cost generics.